News

Search:

As Regulatory Problems Accumulate In India, Clinical Trials Sector Looks to Flee

0 Likes

Can regulatory oversight simultaneously be both too much and not enough? Such is the case of India, reports The Economic Times, whose regulated industry is protesting both its increasingly strict Read More...

Tags:

CDSCO

Clinical Trials

India

Industry

Problems

EMA Looks Back on a Tough Year as it Forges Ahead

0 Likes

Kent Woods wants stakeholders to know he understands: 2011 was a tough year.As Chair of the European Medicines Agency’s (EMA) Management Board and head of the UK’s Medicines and Healthcare products Read More...

Tags:

2011

Approvals

EMA

Inspections

Problems

Rasi

report

Trends

Woods

Warning Letter Analysis: FDA Warning Letters Cite Companies for Marketing, CGMP, Design Deficiencies

1 Likes

The US Food and Drug Administration (FDA) released five warning letters previously issued to companies in the healthcare product sector, including three medical device companies, one pharmaceutical Read More...

Tags:

CGMP

Deficiencies

FD&C Act

FDA

Problems

warning letter

Warning Letter Analysis

J&J Earnings Drag as Regulatory Problems Accumulate

0 Likes

Life sciences giant Johnson & Johnson (J&J) managed to increase first quarter profits by 12.5% despite a decrease in revenue of 0.2%, the company said in a statement.But the company’s profits were Read More...

Tags:

Antipsychotic

DOJ

EMA

Fine

Forecast

Gross

Issues

J&J

Johnson & Johnson

Lawsuit

Problems

Profit

Prosecutors

Regulatory

Revenue

Risperdal

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

As Regulatory Problems Accumulate In India, Clinical Trials Sector Looks to Flee

EMA Looks Back on a Tough Year as it Forges Ahead

Warning Letter Analysis: FDA Warning Letters Cite Companies for Marketing, CGMP, Design Deficiencies

J&J Earnings Drag as Regulatory Problems Accumulate

Get RF Today